Types of Cancer We Treat

Glioma & Astrocytoma in Adults

We have experience in treating the most complex types of gliomas and astrocytomas. Our nationally known team of neurosurgeons, neuro-oncologists, radiologists, radiation oncologists, and neuropathologists partners to create a customized treatment plan for you.

Your team of specialists uses sophisticated diagnostic techniques, such as advanced MRI and precision molecular diagnosis, which determines the tumor’s specific molecular makeup.

Treatment may include targeted drugs, immunotherapy, and treatments provided through cutting-edge clinical trials. We also offer Gamma Knife® radiosurgery, a targeted treatment that provides an alternative to surgery and radiation therapy. Ultimately, we personalize a care plan just for you.

Meet Our Doctors
Neurosurgeon Dr. John Golfinos
Our Approach to Glioma & Astrocytoma in Adults Treatment Our Approach to Glioma & Astrocytoma in Adults Treatment
Diagnosis
Diagnosing Glioma and Astrocytoma
Surgery
Surgery for Glioma and Astrocytoma
Gamma Knife Radiosurgery
Gamma Knife Radiosurgery for Glioma and Astrocytoma
Radiation Therapy
Radiation Therapy for Glioma and Astrocytoma
Chemotherapy
Chemotherapy for Glioma and Astrocytoma
Immunotherapy
Chemotherapy for Glioma and Astrocytoma

Related News

Military Technology Aids Precision-Guided Neurosurgery
Read Story

Clinical Trials and Research Studies

Phase 2

A PHASE II RANDOMIZED TRIAL OF PROTON VS. PHOTON THERAPY (IMRT) FOR COGNITIVE PRESERVATION IN PATIENTS WITH IDH MUTANT LOW TO INTERMEDIATE GRADE GLIOMAS

Learn More

Phase 2

ACNS1721: A Phase 2 Study of Veliparib (ABT-888 IND # 139199) and Local Irradiation Followed by Maintenance Veliparib and Temozolomide in Patients with Newly Diagnosed High-Grade Glioma (HGG) without H3 K27M or BRAFV600E Mutations

Learn More

Phase 2

APEC1621J: NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE)-PHASE 2 SUBPROTOCOL OF BVD-523FB (ULIXERTINIB) IN PATIENTS WITH TUMORS HARBORING ACTIVATING MAPK PATHWAY MUTATIONS

Learn More

Phase 2

A phase II open-label single arm trial of nivolumab ipilimumab and short-course radiotherapy in adults with newly diagnosed MGMT unmethylated glioblastoma

Learn More
View All Related Clinical Trials (12)